Elevated levels of atrial natriuretic peptide during aldosterone escape

J. P. Granger, John C Jr. Burnett, J. C. Romero, T. J. Opgenorth, J. Salazar, M. Joyce

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Escape from the sodium-retaining effects of aldosterone (ALDO) is thought to occur as a result of natriuretic compensatory mechanisms triggered by extracellular fluid volume expansion. The purpose of the present study was to determine whether increases in plasma levels of atrial natriuretic peptide occur during ALDO escape in conscious dogs (n = 6) maintained on a fixed sodium intake (60 meq/day). Infusion of ALDO at a rate of 15 μg·kg-1·day-1 for 6 days decreased sodium excretion (U(Na)V) from 59.1 ± 4.0 to 36.2 ± 5.7 meq/day on day 1, and then U(Na)V gradually returned to control levels by day 5 of ALDO infusion. Net cumulative sodium balance progressively increased during ALDO infusion, reaching a peak value of 88.8 ± 21.3 meq/day on day 5. Mean arterial pressure increased from 85 ± 3 to 95 ± 4 mmHg, and plasma renin activity decreased from 1.32 ± 0.27 to 0.32 ± 0.07 ng angiotensin (ANG) I·ml-1·h-1 during ALDO infusion. Plasma levels of atrial natriuretic peptide averaged 67.5 ± 8.9 pgm/l during control and increased to a peak value of 120 ± 18 pg/ml by day 4 of ALDO infusion. Three to four days after ALDO infusion was stopped, plasma levels of atrial natriuretic peptide averaged 46 ± 5 and 50 ± 6 pg/ml, respectively. In summary, escape from the sodium-retaining effects of ALDO is associated with significant increases in the circulatory levels of atrial natriuretic peptide.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume252
Issue number5
StatePublished - 1987

Fingerprint

Atrial Natriuretic Factor
Aldosterone
Sodium
Extracellular Fluid
Angiotensins
Renin
Arterial Pressure
Dogs

ASJC Scopus subject areas

  • Physiology

Cite this

Elevated levels of atrial natriuretic peptide during aldosterone escape. / Granger, J. P.; Burnett, John C Jr.; Romero, J. C.; Opgenorth, T. J.; Salazar, J.; Joyce, M.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 252, No. 5, 1987.

Research output: Contribution to journalArticle

@article{c1811b2293e247bc95d282086a5b7628,
title = "Elevated levels of atrial natriuretic peptide during aldosterone escape",
abstract = "Escape from the sodium-retaining effects of aldosterone (ALDO) is thought to occur as a result of natriuretic compensatory mechanisms triggered by extracellular fluid volume expansion. The purpose of the present study was to determine whether increases in plasma levels of atrial natriuretic peptide occur during ALDO escape in conscious dogs (n = 6) maintained on a fixed sodium intake (60 meq/day). Infusion of ALDO at a rate of 15 μg·kg-1·day-1 for 6 days decreased sodium excretion (U(Na)V) from 59.1 ± 4.0 to 36.2 ± 5.7 meq/day on day 1, and then U(Na)V gradually returned to control levels by day 5 of ALDO infusion. Net cumulative sodium balance progressively increased during ALDO infusion, reaching a peak value of 88.8 ± 21.3 meq/day on day 5. Mean arterial pressure increased from 85 ± 3 to 95 ± 4 mmHg, and plasma renin activity decreased from 1.32 ± 0.27 to 0.32 ± 0.07 ng angiotensin (ANG) I·ml-1·h-1 during ALDO infusion. Plasma levels of atrial natriuretic peptide averaged 67.5 ± 8.9 pgm/l during control and increased to a peak value of 120 ± 18 pg/ml by day 4 of ALDO infusion. Three to four days after ALDO infusion was stopped, plasma levels of atrial natriuretic peptide averaged 46 ± 5 and 50 ± 6 pg/ml, respectively. In summary, escape from the sodium-retaining effects of ALDO is associated with significant increases in the circulatory levels of atrial natriuretic peptide.",
author = "Granger, {J. P.} and Burnett, {John C Jr.} and Romero, {J. C.} and Opgenorth, {T. J.} and J. Salazar and M. Joyce",
year = "1987",
language = "English (US)",
volume = "252",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Elevated levels of atrial natriuretic peptide during aldosterone escape

AU - Granger, J. P.

AU - Burnett, John C Jr.

AU - Romero, J. C.

AU - Opgenorth, T. J.

AU - Salazar, J.

AU - Joyce, M.

PY - 1987

Y1 - 1987

N2 - Escape from the sodium-retaining effects of aldosterone (ALDO) is thought to occur as a result of natriuretic compensatory mechanisms triggered by extracellular fluid volume expansion. The purpose of the present study was to determine whether increases in plasma levels of atrial natriuretic peptide occur during ALDO escape in conscious dogs (n = 6) maintained on a fixed sodium intake (60 meq/day). Infusion of ALDO at a rate of 15 μg·kg-1·day-1 for 6 days decreased sodium excretion (U(Na)V) from 59.1 ± 4.0 to 36.2 ± 5.7 meq/day on day 1, and then U(Na)V gradually returned to control levels by day 5 of ALDO infusion. Net cumulative sodium balance progressively increased during ALDO infusion, reaching a peak value of 88.8 ± 21.3 meq/day on day 5. Mean arterial pressure increased from 85 ± 3 to 95 ± 4 mmHg, and plasma renin activity decreased from 1.32 ± 0.27 to 0.32 ± 0.07 ng angiotensin (ANG) I·ml-1·h-1 during ALDO infusion. Plasma levels of atrial natriuretic peptide averaged 67.5 ± 8.9 pgm/l during control and increased to a peak value of 120 ± 18 pg/ml by day 4 of ALDO infusion. Three to four days after ALDO infusion was stopped, plasma levels of atrial natriuretic peptide averaged 46 ± 5 and 50 ± 6 pg/ml, respectively. In summary, escape from the sodium-retaining effects of ALDO is associated with significant increases in the circulatory levels of atrial natriuretic peptide.

AB - Escape from the sodium-retaining effects of aldosterone (ALDO) is thought to occur as a result of natriuretic compensatory mechanisms triggered by extracellular fluid volume expansion. The purpose of the present study was to determine whether increases in plasma levels of atrial natriuretic peptide occur during ALDO escape in conscious dogs (n = 6) maintained on a fixed sodium intake (60 meq/day). Infusion of ALDO at a rate of 15 μg·kg-1·day-1 for 6 days decreased sodium excretion (U(Na)V) from 59.1 ± 4.0 to 36.2 ± 5.7 meq/day on day 1, and then U(Na)V gradually returned to control levels by day 5 of ALDO infusion. Net cumulative sodium balance progressively increased during ALDO infusion, reaching a peak value of 88.8 ± 21.3 meq/day on day 5. Mean arterial pressure increased from 85 ± 3 to 95 ± 4 mmHg, and plasma renin activity decreased from 1.32 ± 0.27 to 0.32 ± 0.07 ng angiotensin (ANG) I·ml-1·h-1 during ALDO infusion. Plasma levels of atrial natriuretic peptide averaged 67.5 ± 8.9 pgm/l during control and increased to a peak value of 120 ± 18 pg/ml by day 4 of ALDO infusion. Three to four days after ALDO infusion was stopped, plasma levels of atrial natriuretic peptide averaged 46 ± 5 and 50 ± 6 pg/ml, respectively. In summary, escape from the sodium-retaining effects of ALDO is associated with significant increases in the circulatory levels of atrial natriuretic peptide.

UR - http://www.scopus.com/inward/record.url?scp=0023214567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023214567&partnerID=8YFLogxK

M3 - Article

C2 - 2953258

AN - SCOPUS:0023214567

VL - 252

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5

ER -